Related Experiment Video

Updated: Aug 11, 2026

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

Applications of molecular imaging in cancer gene therapy

Meera Iyer1, Makoto Sato, Mai Johnson

  • 1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles 90095, USA.

Current Gene Therapy
|February 7, 2006
PubMed

Insights

Molecular imaging enhances cancer gene therapy by enabling real-time monitoring of gene expression. This review covers positron emission tomography (PET) and bioluminescence imaging (BLI) for improved treatment efficacy and safety.

Area of Science:

  • Oncology
  • Molecular Imaging
  • Gene Therapy

Background:

  • Gene therapy offers a flexible approach for diverse cancers.
  • Current gene therapy success is limited by the inability to monitor gene expression in vivo.
  • Molecular imaging can bridge this gap for real-time assessment.

Purpose of the Study:

  • To review the application of molecular imaging in cancer gene therapy.
  • To discuss strategies for enhancing cancer gene therapy and imaging.
  • To highlight the potential of imaging-guided gene therapy.

Main Methods:

  • Review of positron emission tomography (PET) in gene therapy.
  • Review of bioluminescence imaging (BLI) in gene therapy.
  • Discussion of strategies for integrating imaging and gene therapy.

Main Results:

  • PET-guided gene therapy has been implemented in clinical studies.
  • PET and BLI are key modalities for pre-clinical and clinical gene therapy.
  • Integration of imaging allows for real-time monitoring and protocol refinement.

Conclusions:

  • Molecular imaging is crucial for advancing cancer gene therapy.
  • Improved monitoring enhances the efficacy and safety of gene therapy protocols.
  • Future clinical trials can benefit from imaging-guided gene therapy approaches.

More Related Videos

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Reporter Genes02:11

Reporter Genes

Reporter genes are a type of protein-coding gene that are often tagged to a gene of interest. Once inside a target cell, reporter genes usually produce visually identifiable characteristics like fluorescence and luminescence when expressed along with the gene of interest. Thus, reporter genes “report” the presence or absence of genes of interest in an organism, determine the gene expression pattern, or track the physical location of a DNA segment or protein in the cell.
Commonly used reporter...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...